Clinical Trial Update: Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of SR58611A co-administered with escitalopram in adults with major depressive disorder. The study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• SR58611A

Snippet

Sponsor: Sanofi | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED